Related Experiment Video
Updated: May 13, 2026
06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
[Gastrointestinal bleeding after treatment with ticagrelor]
Jacob Hauge1, Rikke Kragh, Birgitte Klindt Poulsen
1Medicinsk Afdeling, Sygehus Thy-Mors, Denmark. dr.jacob.hauge@gmail.com
Ugeskrift for Laeger
|March 14, 2013
Summary
Ticagrelor offers better outcomes for acute coronary syndrome (ACS) but increases bleeding risk. This case highlights the challenge of managing major bleeding without an antidote for ticagrelor in ACS patients.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Ticagrelor is a reversible P2Y12 inhibitor used for acute coronary syndrome (ACS).
- Ticagrelor demonstrates superior outcomes compared to clopidogrel in ACS patients, as evidenced by the PLATO study.
- Platelet inhibitors are standard in ACS treatment, but lack specific antidotes, complicating bleeding management.
Observation:
- A 76-year-old woman with chronic obstructive pulmonary disease and ACS was treated with ticagrelor.
- The patient developed a major gastrointestinal bleeding event during treatment.
Findings:
- Ticagrelor, while effective for ACS, is associated with an increased risk of major non-coronary artery bypass graft (non-CABG) bleeding.
- The absence of a specific antidote for ticagrelor poses challenges in managing severe hemorrhage.
Implications:
- This case underscores the critical need for strategies to manage major bleeding in patients treated with ticagrelor.
- Further research into reversal agents or alternative management protocols for ticagrelor-associated bleeding is warranted.
Related Concept Videos
01:28Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
01:24Esophageal Varices-I: Introduction
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
01:23Gastritis III: Clinical Manifestations and Management
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...